Clinical Trial Update: Breast Cancer - Anti-Progestin Prevention Study 1 [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for anti-progestin prevention in breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Manchester University NHS Foundation Trust | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED